Literature DB >> 3082591

The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy.

S F Grimmer, D J Back, M L Orme, A Cowie, I Gilmore, J Tjia.   

Abstract

The bioavailability of ethinyloestradiol and levonorgestrel has been studied in 5 young women with an ileostomy following surgery for ulcerative colitis and compared to that in 5 control subjects. Single i.v. and oral doses of both drugs were administered and the bioavailability calculated from the ratio of the two areas under the plasma concentration versus time curve for the two drugs. The mean bioavailability of ethinyloestradiol in the patients with an ileostomy was 55.4 +/- 10.9% (+/- S.D.) compared to a control value of 45.0 +/- 6.1% (p greater than or equal to 0.1). The mean bioavailability of levonorgestrel in the ileostomy patients was 85.2 +/- 13.1% compared to 104.6 +/- 22.3% in the controls (p greater than or equal to 0.1). Women who have an ileostomy following lower bowel surgery can rely on their oral contraceptive preparations being absorbed in the normal way.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Estrogen--analysis; Contraceptive Agents, Estrogen--pharmacodynamics; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--analysis; Contraceptive Agents, Female--pharmacodynamics; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--analysis; Contraceptive Agents, Progestin--pharmacodynamics; Contraceptive Agents--administraction and dosage; Contraceptive Agents--analysis; Contraceptive Agents--pharmacodynamics; Diseases; Endocrine System; Ethinyl Estradiol--administraction and dosage; Ethinyl Estradiol--analysis; Ethinyl Estradiol--pharmacodynamics; Family Planning; Gastrointestinal Effects; Hormones; Levonorgestrel--administraction and dosage; Levonorgestrel--analysis; Levonorgestrel--pharmacodynamics; Physiology; Reproductive Control Agents; Surgery; Treatment

Mesh:

Substances:

Year:  1986        PMID: 3082591     DOI: 10.1016/0010-7824(86)90032-6

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

1.  Unintended pregnancies and contraceptive use.

Authors: 
Journal:  BMJ       Date:  1991-03-30

Review 2.  Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.

Authors:  Lori M Gawron; Jessica Sanders; Katelyn P Steele; Ann D Flynn
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 3.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

4.  Systematic review of drug bioavailability following gastrointestinal surgery.

Authors:  Manuela Moreno Santamaría; José Javier Arenas Villafranca; Jimena Abilés; Alberto Fernández López; Lucia Visiedo Rodas; Begoña Tortajada Goitia; Pilar Utrilla Navarro
Journal:  Eur J Clin Pharmacol       Date:  2018-08-22       Impact factor: 2.953

Review 5.  Contraceptive Considerations for Women with Gastrointestinal Disorders.

Authors:  Aparna Sridhar; Carrie A Cwiak; Andrew M Kaunitz; Rebecca H Allen
Journal:  Dig Dis Sci       Date:  2016-11-24       Impact factor: 3.199

Review 6.  Clinical pharmacokinetics of contraceptive steroids. An update.

Authors:  G M Shenfield; J M Griffin
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 7.  Levonorgestrel. Clinical pharmacokinetics.

Authors:  K Fotherby
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

Review 8.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

9.  Fertility and Contraception in Women With Inflammatory Bowel Disease.

Authors:  Jason Martin; Sunanda V Kane; Linda A Feagins
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-02

Review 10.  Oral contraceptives. Are drug interactions of clinical significance?

Authors:  G M Shenfield
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.